Year: 2013
Type: article
Abstract: Although therapy directed against VEGF has produced clinical benefit, an understanding of responsive tumor characteristics is lacking. Blood vessel location relative to tumor cells and stromal factors may influence tumor susceptibility to VEGF-targeted therapy. Clinical validation of this potential biomarker is needed to influence clinical practice.
Source: Clinical Cancer Research
Author: Brian I. Rini
Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2171228060
